Abstract
ABSTRACT
The emergence of Acinetobacter baumannii during recent decades as an important nosocomial pathogen responsible of worldwide, intensively documented, outbreaks has resulted in a need for effective epidemiological typing methods. Throughout the years, many typing methods for A. baumannii epidemiological studies have been proposed from phenotypic to molecular methods. Currently, the use of phenotypic typing methods have declined considerably and been progressively replaced by molecular methods. In this review, we introduce the current molecular methods available for A. baumannii typing. Each method has its own advantages and disadvantages, and the selection of an appropriate genotyping method depends on studied objectives. This review sheds light on questions in different epidemiological settings and most molecular methods used to fit these objectives.
Papers of special note have been highlighted as: • of interest; •• of considerable interest.
References
- 1 . Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int. J. Infect. Dis. 17, e802–e805 (2013).
- 2 . The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front. Microbiol. 3, 148 (2012).
- 3 . Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21(3), 538 (2008).
- 4 . Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist Updat. 15(4), 237–247 (2012).•• Analysis of global population structure of Acinetobacter baumannii on selected subset of isolates with focus on the presence of resistance mechanisms.
- 5 . Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41(1), 11–19 (2013).•• Overview of the evolution of current genotyping methods used in A. baumannii, and a global epidemiology of both clonal lineages and carbapenem resistance in clinical strains.
- 6 . Typing Acinetobacter strains: applications and methods. In: Acinetobacter Biology and Pathogenesis. Bergogne-Bérézin E, Friedman H, Bendinelli M (Eds). Springer, NY, USA, 85–104 (2008).
- 7 . Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54(10), 4168–4177 (2010).
- 8 Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J. Clin. Microbiol. 35(12), 3071–3077 (1997).• Quality-controlled reagents, standardized DNA extraction and standardized amplification conditions can produce inter-laboratory reproducible PCR-based fingerprinting.
- 9 . Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting. J. Clin. Microbiol. 32(11), 2635–2640 (1994).
- 10 . Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65(2), 233–238 (2010).• Delineation of eight international clonal linages by DiversiLab™ (bioMérieux, Marcy l'Etoile, France).
- 11 . Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J. Med. Microbiol. 53(2), 147 (2004).
- 12 Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J. Clin. Microbiol. 34(6), 1519–25 (1996).•• First evidence of the presence of two european clones (clone I and II) by using multiple typing methods.
- 13 Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43(9), 4328–4335 (2005).• Development of standard and inter-laboratory reproducible protocol for pulsed-field gel elctrophoresis of A. baumannii with Apa I as a restrioction enzyme.
- 14 Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J. Clin. Microbiol. 49(2), 539–548 (2011).• Development of first validated multiple-locus variable number of tandem repeat analysis scheme for A. baumannii as well as a multiple-locus variable number of tandem repeat analysis database.
- 15 . Variable number tandem repeat loci providing discrimination within widespread genotypes of Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 28(5), 499–507 (2009).
- 16 Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by Multiple Locus Variable Number of Tandem Repeats Analysis. PLoS ONE 7(9), e44597 (2012).
- 17 Multiple-Locus Variable-Number Tandem-Repeat Analysis of Acinetobacter baumannii in China: comparison with PFGE typing. J. Clin. Microbiol. 51(4), 1263–1268 (2013).
- 18 . Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. Clin. Microbiol. 49(3), 875–882 (2011).
- 19 . Sequence-based typing of adeB as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii. J. Clin. Microbiol. 43(10), 5327–5331 (2005).
- 20 . Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44(3), 827 (2006).
- 21 . OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin. Microbiol. Infect. 14(3), 268–275 (2008).
- 22 . Acinetobacter baumannii in human body louse. Emerg. Infect. Dis. 10(9), 1671–1673 (2004).
- 23 . Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13(8), 807–815 (2007).
- 24 . The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 5(4), e10034 (2010).• Development of the second multilocus sequence typing scheme for A. baumannii.
- 25 . Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43(9), 4382–4390 (2005).• Development of first multilocus sequence typing scheme for A. baumannii.
- 26 Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J. Clin. Microbiol. 44(8), 2921–2932 (2006).
- 27 High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J. Hosp. Infect. 75(1), 37–41 (2010).
- 28 Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc. Natl Acad. Sci. 108(33), 13758–13763 (2011).
- 29 New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. mBio 5(1), e00963–e00913 (2014).
- 30 . Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol. 11, 224 (2011).
- 31 Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43(7), 3074–3082 (2005).
- 32 . Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings. Chin. Med. J. (Engl.) 122(3), 301–306 (2009).
- 33 . Identification of a marker for two lineages within the GC1 clone of Acinetobacter baumannii. J. Antimicrob. Chemother. 69(2), 557–8 (2014).
- 34 . Antibiotic resistance islands in A320 (RUH134), the reference strain for Acinetobacter baumannii global clone 2. J. Antimicrob. Chemother. 67(2), 335–338 (2012).
- 35 . Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PLoS ONE 8(7), e70329 (2013).
- 36 . Use of the accessory genome for characterization and typing of Acinetobacter baumannii. J. Clin. Microbiol. 49(4), 1260–1266 (2011).
- 37 . DNA fingerprinting techniques applied to the identification, taxonomy and community analysis of Prokaryotes. In: Molecular Identification, Systematics, and Population Structure of Prokaryotes. Stackebrandt E (Ed.). Springer-Verlag, Berlin; Heidelberg; NY, USA, 51–71 (2006).
- 38 . Suitable restriction enzyme for standardization of pulsed-field gel electrophoresis protocol and interlaboratory comparison of Acinetobacter baumannii. J. Microbiol. Immunol. Infect. 46(3), 195–201 (2013).• Evaluation of most suitable restriction enzymes with rare cutting sites for a pulsed-field gel electrophoresis protocol for A. baumannii.
- 39 A prevalent, multiresistant clone of Acinetobacter baumannii in southeast England. J. Hosp. Infect. 58(3), 170–179 (2004).
- 40 The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn. J. Infect. Dis. 62(5), 372–377 (2009).
- 41 Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 49(11), 3849–3854 (2011).
- 42 Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000–09). J. Antimicrob. Chemother. 66(12), 2767–2772 (2011).
- 43 Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases--a multicentre study. Int. J. Antimicrob. Agents 36(5), 430–435 (2010).
- 44 . Use of different PCR-based DNA fingerprinting techniques and pulsed-field gel electrophoresis to investigate the epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Diagn. Microbiol. Infect. Dis. 29(1), 19–28 (1997).
- 45 . Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period. New Microbiol. 35(2), 199–206 (2012).
- 46 Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33(9), 2233–2239 (1995).
- 47 Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin. Microbiol. Infect. 13, 1–46 (2007).•• An update of guidelines and criteria for evaluation, application and results interpretation of bacterial typing methods.
- 48 . Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis. Am. J. Infect. Control. 37(1), 56–64 (2009).
- 49 . Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48(11), 4051–4056 (2010).
- 50 OXA-23-producing Acinetobacter Baumannii : a new hotspot of diversity in Rio De Janeiro? J. Antimicrob. Chemother. 66(1), 62–65 (2011).
- 51 . Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific Nations: Report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63(1), 55–59 (2009).
- 52 . Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of blaOXA-51-like genes. J. Clin. Microbiol. 48(7), 2476–2483 (2010).
- 53 . Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 14(2), 161–167 (2008).
- 54 Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan. Infect. Control Hosp. Epidemiol. 30(1), 34–38 (2009).
- 55 . Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19(24), 6823–6831 (1991).
- 56 . PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6(12), 635–643 (2000).
- 57 . Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of Pulsed-Field Gel Electrophoresis and Repetitive Sequence–Based Polymerase Chain Reaction. Infect. Control Hosp. Epidemiol. 27(9), 981–983 (2006).
- 58 Endemic Acinetobacter baumannii in a New York hospital. PloS ONE 6(12), e28566 (2011).
- 59 . Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and Multilocus Sequence Typing. J. Clin. Microbiol. 50(11), 3493–3500 (2012).
- 60 Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methods. PloS ONE 7(4), e33443 (2012).
- 61 . Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis 26(13), 2567–2582 (2005).
- 62 . Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54(9), 3569–3577 (2010).
- 63 Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190(24), 8053–8064 (2008).
- 64 Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity. BMC Genomics 12(1), 291 (2011).
- 65 The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63(12), 1068–1074 (2011).
- 66 . Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41(8), 3542–3547 (2003).
- 67 VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg. Infect. Dis. 12(8), 1214–1222 (2006).
- 68 . Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J. Clin. Microbiol. 32(7), 1816–1819 (1994).
- 69 . Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12(9), 826–836 (2006).
- 70 Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 155(2), 105–112 (2004).• First description of third European clone.
- 71 . Ribotyping in clinical microbiology. In: Medical Biomethods Handbook. Walker JM, Rapley R (Eds). Humana Press, NY, US, 573–581 (2005).
- 72 . Molecular epidemiology of Acinetobacter species. In: Acinetobacter Biology and Pathogenesis. Bergogne-Bérézin E, Friedman H, Bendinelli M (Eds). Springer, NY, USA, 61–83 (2008).
- 73 . The diversity of the genus Acinetobacter. In: Acinetobacter Molecular Microbiology. Gerischer U (Ed.). Caister Academic Press, Norfolk, UK, 1–34 (2008).
- 74 . Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infect. Genet. Evol. 14, 92–97 (2013).
- 75 . Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55(3), 947–953 (2011).
- 76 Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation. J. Hosp. Infect. 79(2), 134–140 (2011).
- 77 Identification of a novel Acinetobacter baumannii clone in a US hospital outbreak by multilocus polymerase chain reaction/electrospray-ionization mass spectrometry. Diagn. Microbiol. Infect. Dis. 72(1), 14–19 (2012).
- 78 . OXA β-Lactamases. Clin. Microbiol. Rev. 27(2), 241–263 (2014).
- 79 . Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44(8), 2974–2976 (2006).
- 80 . Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates. J. Clin. Microbiol. 50(6), 1900–1904 (2012).
- 81 Single locus sequence-based typing of blaOXA-51-like gene for rapid classification of Acinetobacter baumannii clinical isolates to international clones. J. Clin. Microbiol. 52(5), 1653–1657 (2014).
- 82 . Comparative studies of the Acinetobacter genus and the species identification method based on the recA sequences. Mol. Cell. Probes 16(1), 1–11 (2002).
- 83 Detection of Acinetobacter baumannii in human head and body lice from Ethiopia and identification of new genotypes. Int. J. Infect. Dis. 16(9), e680–e683 (2012).
- 84 Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple mediterranean hospitals. J. Antimicrob. Chemother. 63(4), 828–830 (2009).
- 85 Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J. Clin. Microbiol. 48(4), 1223–1230 (2010).
- 86 Acinetobacter baumannii sequence typing home page. www.hpa-bioinformatics.org.uk/AB/home.php.
- 87 Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J. Med. Microbiol. 60(Pt 4), 515–521 (2011).
- 88 . A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages. Microb. Drug Resist. Larchmt. N. 17(4), 545–549 (2011).
- 89 . Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. Clin. Microbiol. Infect. 17(10), 1524–1528 (2011).
- 90 . Exploring the concept of clonality in bacteria. In: Genomics, Proteomics, and Clinical Bacteriology. Woodford N, Johnson AP (Eds). Humana Press, NY, USA, 323–352 (2004).
- 91 Acinetobacter baumannii MLST databases. http://pubmlst.org/abaumannii.
- 92 Institut Pasteur MLST databases. www.pasteur.fr/mlst.
- 93 Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn. Microbiol. Infect. Dis. 64(1), 43–51 (2009).
- 94 . Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. 17(8), 1275–1279 (2011).
- 95 . PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J. Mol. Diagn. JMD 14(4), 295–304 (2012).
- 96 Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J. Antimicrob. Chemother. 65(8), 1807–1818 (2010).
- 97 Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51(2), 603–606 (2013).